DIAZOXIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for diazoxide and what is the scope of freedom to operate?
Diazoxide
is the generic ingredient in three branded drugs marketed by Teva Branded Pharm, Abraxis Pharm, Schering, E5 Pharma Inc, and Novitium Pharma, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for diazoxide. Three suppliers are listed for this compound.
Summary for DIAZOXIDE
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 5 |
NDAs: | 6 |
Drug Master File Entries: | 5 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 112 |
Clinical Trials: | 41 |
Patent Applications: | 6,233 |
Drug Prices: | Drug price trends for DIAZOXIDE |
What excipients (inactive ingredients) are in DIAZOXIDE? | DIAZOXIDE excipients list |
DailyMed Link: | DIAZOXIDE at DailyMed |
Recent Clinical Trials for DIAZOXIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Johns Hopkins University | Phase 1 |
Columbia University | Phase 1 |
Soleno Therapeutics, Inc. | Phase 2 |
Medical Subject Heading (MeSH) Categories for DIAZOXIDE
Anatomical Therapeutic Chemical (ATC) Classes for DIAZOXIDE
US Patents and Regulatory Information for DIAZOXIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | HYPERSTAT | diazoxide | INJECTABLE;INJECTION | 016996-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Novitium Pharma | DIAZOXIDE | diazoxide | SUSPENSION;ORAL | 210799-001 | Jul 8, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva Branded Pharm | PROGLYCEM | diazoxide | CAPSULE;ORAL | 017425-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abraxis Pharm | DIAZOXIDE | diazoxide | INJECTABLE;INJECTION | 071519-001 | Aug 26, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Branded Pharm | PROGLYCEM | diazoxide | CAPSULE;ORAL | 017425-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Branded Pharm | PROGLYCEM | diazoxide | SUSPENSION;ORAL | 017453-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
E5 Pharma Inc | DIAZOXIDE | diazoxide | SUSPENSION;ORAL | 211050-001 | Dec 20, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |